Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Effective and Efficient GIS Use in Transportation Planning Using an Integrated Vector and Raster System and Pseudo English as a Programming Language

    SBC: Susquehanna Resources And            Topic: N/A

    N/A

    SBIR Phase II 1996 Department of Transportation
  2. Exact Disease Cluster Statostocs for Structured Settings

    SBC: Applied Biomathematics Inc            Topic: N/A

    Health professionals must often analyze disease cluster allegations made by concerned citizens who sense patterns within small structured environments. Examples include households, families, sibships, wards, cellblocks, classrooms, job types, age classes, and locations within a building. It is crucial for the health professional to know what tests are best in these small-environment problems. A fe ...

    SBIR Phase II 1996 Department of Health and Human Services
  3. AN ELECTRICAL APPROACH FOR IN VITRO TOXICOLOGY

    SBC: APPLIED BIOPHYSICS, INC.            Topic: N/A

    WE HAVE BEEN DEVELOPING A NEW MEANS TO ELECTRICALLY STUDY ANIMAL CELLS GROWN IN TISSUE CULTURE AND INTEND TO MAKE A COMMERCIAL DEVICE SUITABLE FOR USE IN THE MEDICAL/BIOLOGICAL RESEACH AND TESTING MARKET. THE INSTRUMENTAL METHOD, REFERRED TO AS ECIS (ELECTRIC CELL-SUBSTRATE IMPEDANCE SENSOR), IS A NON-INVASIVE TECHNIQUE THAT MEASURES SEVERAL PARAMETERS RELATED TO CELL BEHAVIOR, SOME OF WHICH HAVE ...

    SBIR Phase II 1996 Department of Health and Human Services
  4. Title missing

    SBC: Appolo Research Corp.            Topic: N/A

    N/A

    SBIR Phase II 1996 Department of Health and Human Services
  5. Design of Specialized Protocol Software

    SBC: Ck Software, Inc.            Topic: N/A

    This proposal addresses the need to develop products which will help participants in health care assquality and level of care furnished to patients. We will develop a prototype ¿Protocol Engine¿, withdesigned for personal computers and computer networks, to allow protocols to be defined and customizspecific needs of the organization; to link and/or access data from other medical software package ...

    SBIR Phase II 1996 Department of Health and Human Services
  6. Expression of Dengue Viral Proteins in Drosophila Cells

    SBC: Hawaii Biotech, Inc.            Topic: N/A

    Dengue virus causes dengue fever, a debilitating illness marked by high fever, headache, muscleand joint pain, and rash. The more severe forms of the illness, dengue hemorrhagic fever and dengueshock syndrome, are life threatening and are a principal cause of hospitalization among children inSoutheast Asia. Globally, the four serotypes of dengue are responsible for up to 100 million infectionsannu ...

    SBIR Phase II 1996 Department of Health and Human Services
  7. Analyzing Toxicity to Mammalian Cells by Flow Cyometry

    SBC: Litron Laboratories Ltd            Topic: N/A

    Our Phase I research program is based on years of research which strongly suggest that high speed f(FCM) is a technology that can significantly improve toxicity assays. Highly reliable clastogen andhave been developed in our laboratories where FCM has played a major role in processing and analyzinfollowing exposure. In both cases, a significant improvement over conventional assays has resulted.Pha ...

    SBIR Phase II 1996 Department of Health and Human Services
  8. Caged Metal Cluster and Colloid Immunoprobes

    SBC: NANOPROBES INC            Topic: N/A

    New classes of immunolabels will be produced comprising large metal particles encapsulated within coordination shells of stabilizing ligands, the naturally occurring hollow protein apoferritin, or new synthetic inclusion molecules. The new probes will combine the high electron density, ease of visualization and range of sizes available with colloidal gold probes with the non-aggregation, high pene ...

    SBIR Phase II 1996 Department of Health and Human Services
  9. Inhibition of The HIV-1 REV Transactivator

    SBC: ONCOGENE SCIENCE, INC.            Topic: N/A

    Acquired Immunodeficiency Syndrome (AIDS), a disease affecting millions of individuals worldwide, has a high incidence of patient mortality. The etiological agent of this disease, the infectious retrovirus HIV-l, has proven refractory to therapeutic intervention. The drugs used in the clinic today only target the viral reverse transcriptase. At best, such drugs temporarily delay disease progressio ...

    SBIR Phase II 1996 Department of Health and Human Services
  10. CD4 Based In Vivo Imaging Agents For HIV-1 Disease

    SBC: PROGENICS PHARMACEUTICALS, INC.            Topic: N/A

    We will develop two radioiodinated CD4-immunoglobulin chimetric proteins as novel in vivoimaging agents for HIV-1 disease. The two recombinant proteins are CD4-gamma2, a homodimercontaining two chains of a CD4-human IgG2 heavy chain fusion protein; and, CD4-IgG2, a heterotetram-er containing two chains of a CD4-human IgG2 heavy chain fusion protein and two chains of aCD4-human kappa light chain fu ...

    SBIR Phase II 1996 Department of Health and Human Services
US Flag An Official Website of the United States Government